Highlights and cutting-edge advances in hepatobiliary and pancreatic cancer research at the American Society of Clinical Oncology(ASCO)Annual Meeting 2025
10.7659/j.issn.1005-6947.250488
- VernacularTitle:2025年美国临床肿瘤学会(ASCO)年会肝胆胰肿瘤研究热点与前沿动态
- Author:
Chaoman HUANG
1
;
Wenyang LI
;
Yanxi PAN
;
Liang MA
;
Jianhong ZHONG
;
Pingping GUO
;
Yili MA
Author Information
1. 广西医科大学附属肿瘤医院肝胆胰脾外科,广西南宁 530021
- Publication Type:Journal Article
- Keywords:
Liver Neoplasms;
Biliary Tract Neoplasms;
Pancreatic Neoplasms;
ASCO
- From:
Chinese Journal of General Surgery
2025;34(8):1738-1750
- CountryChina
- Language:Chinese
-
Abstract:
The 2025 American Society of Clinical Oncology(ASCO)Annual Meeting was held in Chicago from May 30 to June 3,2025.As one of the largest and most influential academic events in global oncology,the ASCO meeting brought together numerous world-class oncology experts.It focused on the unmet clinical needs in gastrointestinal malignancies such as hepatocellular carcinoma,cholangiocarcinoma,and pancreatic cancer,and presented a wealth of cutting-edge research findings and therapeutic innovations.These advances provide important evidence-based support for the diagnosis and treatment of hepatobiliary and pancreatic cancers.Based on the latest achievements presented at ASCO 2025,this article discusses the hot topics and future directions in the management of hepatobiliary and pancreatic tumors.
